21 New Contract Funding Opportunities Available to Small Businesses for Cancer Research and Technology Development

The National Cancer Institute (NCI) Small Business Innovation Research Program(SBIR) has announced 21 new contract funding opportunities in a range of novel technology areas to help successfully finance and advance innovative cancer-related technologies towards commercialization. These funding opportunities are available to small businesses to support the research and development of many areas of interest to the NCI including: the development of molecular diagnostic assays, anti-cancer agents, imaging agents, health information technology, nanotechnology, and pharmacodynamics. To learn more about NCI's SBIR Programs and these contract funding opportunities, click here.

Contract funding opportunities are only available once a year. We encourage you to apply today!

New Contract Funding Updates:

October 26, 2010 (10:00 a.m. - 12:00 p.m. ET) Pre-Proposal Meeting and Webinar for NCI SBIR Technology Transfer Contract Topics (Topics 298 and 299 Only)

The NCI invites you to a pre-proposal meeting on Technology Transfer Contract Topics 298 and 299. You may join in person at or via webinar. To view event details and register, click here.